NNT = 66) 15% reduction in myocardial infarction 15% reduction in heart failure hospitalization 9% reduction in acute kidney failure These are not trivial numbers
Innovator pricing abroad is still high, generic competition is thin, and the 5,000-crore incremental opportunity Systematix talks about is, in the analysts own framing, largely an export number concentrated in far fewer hands than the domestic chaos suggests
"I have to impress upon people out there that this was hard work for me, especially during the pandemic
Clinicians recommend not continuing GLP-1 medication while severe dehydration or other acute medical issues are being treated, and advise follow-up before restarting therapy
On the right is GIP binding to the GIP receptor, PDB 7RA3
Weight loss typically continues for 12 to 18 months before plateauing